Publications by authors named "Ryan D Watkins"

Claim this Profile
A
Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma models.
Mincheng Yu, Jack W Sample, Irene K Yan, Shohei Takaichi, Jennifer L Tomlinson, Ryan D Watkins

Hepatology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Protein Tyrosine Phosphatase 1B Modulates the Activation of Yes-Associated Protein and Sensitizes to Cytotoxic Chemotherapy in Preclinical Models of Cholangiocarcinoma.
Ryan D Watkins, Jennifer L Tomlinson, EeeLN H Buckarma, Hendrien Kuipers, Danielle M Carlson

Cells· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAP-TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape.
Roberto Alva-Ruiz, Ryan D Watkins, Jennifer L Tomlinson, Jennifer A Yonkus, Amro M Abdelrahman

FEBS Open Bio· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of Procedural Skill Simulation in Health Care in Low- and Middle-Income Countries.
Franziska Pollok, Sarah B Lund, Michael D Traynor, Roberto Alva-Ruiz, Taleen A MacArthur, Ryan D Watkins

Simul Healthc· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma.
Benjamin J Van Treeck, Maria C Olave, Ryan D Watkins, Haiyan Lu, Roger K Moreira

HPB (Oxford)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediastinitis after endobronchial ultrasound with transbronchial needle aspiration resulting in postpneumonectomy empyema.
Nathaniel L Robinson, Ryan D Watkins, Luis F Tapias

JTCVS Tech· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WITHDRAWN: Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma.
Benjamin J Van Treeck, Maria C Olave, Ryan D Watkins, Haiyan Lu, Roger K Moreira

HPB (Oxford)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.
Caitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, Dong-Gi Mun, Nathan W Werneburg, Ryan D Watkins

J Hepatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SHP2 inhibition enhances Yes-associated protein-mediated liver regeneration in murine partial hepatectomy models.
Ryan D Watkins, EeeLN H Buckarma, Jennifer L Tomlinson, Chantal E McCabe, Jennifer A Yonkus

JCI Insight· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-injury outcomes of children with behavioral health disorders.
Michael D Traynor, Ryan D Watkins, Martin D Zielinski, D Dean Potter, Christopher R Moir

J Pediatr Surg· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACP Journal Club. Review: DOACs do not differ from standard anticoagulants for recurrent VTE; factor Xa inhibitors reduce bleeding.
Ryan D Watkins, Matthew T Rondina

Ann Intern Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis